Brief: Kane Biotech Announces Additional Coactiv+™ Animal Health Licensing Agreement
18/04/2023 12:35
April 18 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES ADDITIONAL COACTIV+™ ANIMAL HEALTH
LICENSING AGREEMENT
* KANE BIOTECH - SIGNED A LICENSING AGREEMENT WITH SKOUT'S
HONOR
PET SUPPLY COMPANY FOR ITS PATENTED COACTIV+ TECHNOLOGY IN PET
ORAL CARE APPLICATIONS
Source text for Eikon: ID:nGNX1N7qRn
Further company coverage: KNE.V
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update